Back to search

Article

Could Metformin use reduce abdominal aortic aneurysm risk? A Mendelian randomisation study using known Metformin targets

2023-10-13

Abstract excerpt

<h4>Introduction</h4> An abdominal aortic aneurysm (AAA) is a swelling of the main artery in the body estimated to affect 0.92% of adults (aged 30-79) worldwide. Rupture is often fatal and surgical intervention may be offered if the risk of rupture is high. There is no treatment to prevent AAA or to slow aneurysm growth aside from dietary and lifestyle recommendations. Metformin, a drug prescribed to treat type 2...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0b71f6fe-6a4b-50c4-87ed-37d4dda47d11
DOI
10.1101/2023.10.13.23293381
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Could Metformin use reduce abdominal aortic aneurysm risk? A Mendelian randomisation study using known Metformin targetsDOI 10.1101/2023.10.13.23293381
Select a neighboring publication to make it the new centre.